Literature DB >> 16838119

Effects of Saccharomyces boulardii on intestinal mucosa.

Jean-Paul Buts1, Nadine De Keyser.   

Abstract

Saccharomyces boulardii (S. boulardii) is a non-pathogenic biotherapeutic agent, widely prescribed in a lyophilized form in many countries over the world. S. boulardii acts as a shuttle liberating effective enzymes, proteins and trophic factors during its intestinal transit that improve host immune defenses, digestion, and absorption of nutrients. In addition, S. boulardii secretes during its intestinal transit polyamines, mainly spermine and spermidine that regulate gene expression and protein synthesis. In this review, we will focus on the interactions of the yeast with the host intestinal mucosa.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16838119     DOI： 10.1007/s10620-005-9016-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


  50 in total

1.  Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells.

Authors:  D Czerucka; S Dahan; B Mograbi; B Rossi; P Rampal
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Characteristics of spermidine uptake by isolated rat enterocytes.

Authors:  J Kumagai; R Jain; L R Johnson
Journal:  Am J Physiol       Date:  1989-05

3.  Polyamide profiles of porcine milk and of intestinal tissue of pigs during suckling.

Authors:  D Kelly; T P King; D S Brown; M McFadyen
Journal:  Reprod Nutr Dev       Date:  1991

4.  Microflora-derived polyamines modulate obstruction-induced colonic mucosal hypertrophy.

Authors:  D L Osborne; E R Seidel
Journal:  Am J Physiol       Date:  1989-06

5.  [Prevention of traveler's diarrhea with Saccharomyces boulardii. Results of a placebo controlled double-blind study].

Authors:  H Kollaritsch; H Holst; P Grobara; G Wiedermann
Journal:  Fortschr Med       Date:  1993-03-30

6.  Dose-response relationship and mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhea in rats.

Authors:  Philippe Girard; Yannick Pansart; Ingrid Lorette; Jean-Marie Gillardin
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

7.  Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants.

Authors:  J P Buts; G Corthier; M Delmee
Journal:  J Pediatr Gastroenterol Nutr       Date:  1993-05       Impact factor: 2.839

Review 8.  Polyamine metabolism and function.

Authors:  A E Pegg; P P McCann
Journal:  Am J Physiol       Date:  1982-11

9.  Regulation of ornithine decarboxylase mRNA translation by polyamines. Studies using a cell-free system and a cell line with an amplified ornithine decarboxylase gene.

Authors:  L Persson; I Holm; O Heby
Journal:  J Biol Chem       Date:  1988-03-05       Impact factor: 5.157

10.  Maturation of villus and crypt cell functions in rat small intestine. Role of dietary polyamines.

Authors:  J P Buts; N De Keyser; J Kolanowski; E Sokal; F Van Hoof
Journal:  Dig Dis Sci       Date:  1993-06       Impact factor: 3.199
View more
  20 in total

Review 1.  Twenty-five years of research on Saccharomyces boulardii trophic effects: updates and perspectives.

Authors:  Jean-Paul Buts
Journal:  Dig Dis Sci       Date:  2008-06-05       Impact factor: 3.199

2.  Probiotic yeasts: anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice.

Authors:  Benoît Foligné; Joëlle Dewulf; Pascal Vandekerckove; Georges Pignède; Bruno Pot
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

3.  Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice.

Authors:  Thomas W Hoffmann; Hang-Phuong Pham; Chantal Bridonneau; Camille Aubry; Bruno Lamas; Camille Martin-Gallausiaux; Marco Moroldo; Dominique Rainteau; Nicolas Lapaque; Adrien Six; Mathias L Richard; Emilie Fargier; Marie-Emmanuelle Le Guern; Philippe Langella; Harry Sokol
Journal:  ISME J       Date:  2015-07-28       Impact factor: 10.302

Review 4.  Probiotics in infectious diarrhoea in children: are they indicated?

Authors:  Y Vandenplas; S Salvatore; M Vieira; M Viera; T Devreker; B Hauser
Journal:  Eur J Pediatr       Date:  2007-07-05       Impact factor: 3.183

5.  Lactobacillus acidophilus stimulates the expression of SLC26A3 via a transcriptional mechanism.

Authors:  Geetu Raheja; Varsha Singh; Ke Ma; Redouane Boumendjel; Alip Borthakur; Ravinder K Gill; Seema Saksena; Waddah A Alrefai; Krishnamurthy Ramaswamy; Pradeep K Dudeja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-12-31       Impact factor: 4.052

6.  The effect of Saccharomyces boulardii on reducing irinotecan-induced intestinal mucositis and diarrhea.

Authors:  Atakan Sezer; Ufuk Usta; Irfan Cicin
Journal:  Med Oncol       Date:  2008-12-09       Impact factor: 3.064

7.  Effectiveness of Saccharomyces boulardii in a rat model of colitis.

Authors:  Mujde Soyturk; Saba Mukaddes Saygili; Huseyin Baskin; Ozgul Sagol; Osman Yilmaz; Fatih Saygili; Hale Akpinar
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

8.  Modulation of intestinal inflammation by yeasts and cell wall extracts: strain dependence and unexpected anti-inflammatory role of glucan fractions.

Authors:  Samir Jawhara; Khalid Habib; François Maggiotto; Georges Pignede; Pascal Vandekerckove; Emmanuel Maes; Laurent Dubuquoy; Thierry Fontaine; Yann Guerardel; Daniel Poulain
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

Review 9.  The role of probiotics and prebiotics in inducing gut immunity.

Authors:  Angélica T Vieira; Mauro M Teixeira; Flaviano S Martins
Journal:  Front Immunol       Date:  2013-12-12       Impact factor: 7.561

10.  Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice.

Authors:  Tatiani Uceli Maioli; Brenda de Melo Silva; Michelle Nobre Dias; Nivea Carolina Paiva; Valbert Nascimento Cardoso; Simone Odilia Fernandes; Cláudia Martins Carneiro; Flaviano Dos Santos Martins; Simone de Vasconcelos Generoso
Journal:  J Negat Results Biomed       Date:  2014-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.